Ertapenem

Results: 254



#Item
1Microsoft Word - Arsanis_ASMMicrobe_Press_Release_6.17.16_FINAL_forWebsite.docx

Microsoft Word - Arsanis_ASMMicrobe_Press_Release_6.17.16_FINAL_forWebsite.docx

Add to Reading List

Source URL: static1.squarespace.com

Language: English
2Microorganisms Identified in Central Line-Associated Blood Stream Infections (CLABSI) in Illinois Hospital Intensive Care Units Reporting Period: /2014 A variety of organisms are found to contribute to c

Microorganisms Identified in Central Line-Associated Blood Stream Infections (CLABSI) in Illinois Hospital Intensive Care Units Reporting Period: /2014 A variety of organisms are found to contribute to c

Add to Reading List

Source URL: healthcarereportcard.illinois.gov

Language: English - Date: 2016-03-25 13:35:16
3Carbapenem Non-Susceptible Cases in Utah, 2014 In May 2013, the Utah Department of Health (UDOH) changed the Communicable Disease Rule (Rule R386-702) to include reporting of certain healthcare-associated infections (HAI

Carbapenem Non-Susceptible Cases in Utah, 2014 In May 2013, the Utah Department of Health (UDOH) changed the Communicable Disease Rule (Rule R386-702) to include reporting of certain healthcare-associated infections (HAI

Add to Reading List

Source URL: health.utah.gov

Language: English - Date: 2015-08-03 13:52:56
4MSSA Methicillin-(Oxacillin-) sensible Staphylococcus aureus MRSA Methicillin-(Oxacillin-) resistente Staphylococcus aureus 1 MRSA-Rate in Blutkulturen: 4%

MSSA Methicillin-(Oxacillin-) sensible Staphylococcus aureus MRSA Methicillin-(Oxacillin-) resistente Staphylococcus aureus 1 MRSA-Rate in Blutkulturen: 4%

Add to Reading List

Source URL: www.unispital-basel.ch

Language: English - Date: 2015-12-04 06:35:09
5Epidemiological surveillance of carbapenemase producing enterobacteriacea (CPE) Lessons for the future Béatrice Jans & Prof. Youri Glupczynski

Epidemiological surveillance of carbapenemase producing enterobacteriacea (CPE) Lessons for the future Béatrice Jans & Prof. Youri Glupczynski

Add to Reading List

Source URL: www.wiv-isp.be

Language: English - Date: 2012-10-01 12:36:34
6VetMIC GN-mo Art. No. E395103 VetMIC GP-mo Art. No. E395102 VetMIC E-cocci Art. No. E395100 ! For antimicrobial susceptibility monitoring

VetMIC GN-mo Art. No. E395103 VetMIC GP-mo Art. No. E395102 VetMIC E-cocci Art. No. E395100 ! For antimicrobial susceptibility monitoring

Add to Reading List

Source URL: www.sva.se

Language: English - Date: 2015-03-03 08:02:02
7SWEDRES|2007 A Report on Swedish Antimicrobial Utilisation and Resistance in Human Medicine Swedish Strategic Programme

SWEDRES|2007 A Report on Swedish Antimicrobial Utilisation and Resistance in Human Medicine Swedish Strategic Programme

Add to Reading List

Source URL: soapimg.icecube.snowfall.se

Language: English - Date: 2008-06-09 03:41:02
8Biological effects of nanoparticles of silver, gold, TiO2 and nanoporous silica to selected invertebrate species and bacteria: FP7 project NanoValid Olesja Bondarenko1, Angela Ivask1, Aleksandr Käkinen1,2, Villem Aruoja

Biological effects of nanoparticles of silver, gold, TiO2 and nanoporous silica to selected invertebrate species and bacteria: FP7 project NanoValid Olesja Bondarenko1, Angela Ivask1, Aleksandr Käkinen1,2, Villem Aruoja

Add to Reading List

Source URL: www.ecetoc.org

Language: English - Date: 2014-01-27 05:59:11
9A fact sheet from ReAct – Action on Antibiotic Resistance, www.reactgroup.org First edition 2007 – Last updated May 2008 Burden of Resistance to Multi-Resistant Gram-Negative Bacilli (MRGN) u Gram-negative bacilli li

A fact sheet from ReAct – Action on Antibiotic Resistance, www.reactgroup.org First edition 2007 – Last updated May 2008 Burden of Resistance to Multi-Resistant Gram-Negative Bacilli (MRGN) u Gram-negative bacilli li

Add to Reading List

Source URL: soapimg.icecube.snowfall.se

Language: English - Date: 2009-01-22 11:17:56
10Abstracts Tigecycline, in vitro studies P801 Addition of a biocatalytic oxygen-reducing agent may be required in the absence of fresh media

Abstracts Tigecycline, in vitro studies P801 Addition of a biocatalytic oxygen-reducing agent may be required in the absence of fresh media

Add to Reading List

Source URL: www.blackwellpublishing.com

Language: English - Date: 2005-06-02 07:08:37